2016
[Molecular aspects of vasoprotective peptide KED activity during atherosclerosis and restenosis]
Ventfort peptide supports joint cartilage repair and mobility.
Kozlov KL, Bolotov II, Linkova NS, et al.
Longevity
A blood-vessel peptide extract from Russian longevity research, studied for keeping aging arteries flexible and cholesterol in check. Human evidence is still thin.
Start here
Ventfort is a peptide bioregulator complex extracted from bovine (cow) aorta, studied for supporting aging blood vessels. A 49-patient clinical trial reported a 30% reduction in total cholesterol, and research describes improved function of the blood vessel lining and restored arterial elasticity. It is a research compound, not FDA approved, with limited human trial evidence, taken as capsules under the tongue, by mouth, or by injection.
Ventfort is described in this research as working on cartilage, the smooth tissue that cushions your joints. It encourages chondrocytes, the cells that build cartilage, to produce more of the structural materials cartilage is made from, while reining in the enzymes that break cartilage down. It also calms inflammation inside joint tissue. The combined effect shifts the balance away from cartilage breakdown and toward repair, which is how it is thought to support mobility and joint comfort.
Ventfort is a bioactive peptide complex. Its active sequences switch on growth-factor signaling in chondrocytes (cartilage cells), partly through integrins (proteins that anchor cells to their surroundings). They raise production of type II collagen and aggrecan (the main building materials of cartilage) by switching on MAPK and Wnt/β-catenin pathways (cell messaging routes). They hold back MMPs (enzymes that break down cartilage) by raising TIMPs (the natural blockers of those enzymes). They also lower inflammatory signals in joint tissue by blocking NF-κB (a master switch for inflammation). Together this builds up and repairs cartilage while cutting damaging inflammation.
Evidence check
Very few human studies
Only a handful of small human studies exist. Most of what's claimed about it hasn't been rigorously tested in people yet.
Every numbered marker on this page links to one of the 6 sources at the bottom.
Blood Vessel Health
This peptide helps keep your arteries flexible and stretchy, which matters more as you age because stiff arteries raise blood pressure.
Cholesterol Support
In a clinical trial with 49 people, this peptide lowered total cholesterol by about 30% without the muscle pain some cholesterol drugs cause.
Heart Protection
Works at the cellular level to calm inflammation in blood vessel walls and support the tiny blood vessels that feed your heart and organs.
The most-asked question
The research-reported range is 2 capsules, once daily. Studies used different doses for different situations — find yours:
Vascular health research, First-time users
1 capsule (10 mg) once daily
Khavinson A-3 vascular bioregulator (Ventfort); each capsule contains 10 mg peptide complex from vascular tissue 6. Dietary-supplement form; research/wellness use.
Vascular support, Cyclical anti-aging protocols
2 capsules (20 mg) daily
Standard daily dose (20 mg/day); courses typically repeated every 6 months 6. Sublingual enteric-coated capsules used for buccal absorption.
Intensive vascular research protocols
5–10 mg
Injectable form of the A-3 complex for direct systemic (affecting the whole body) delivery; same course length as oral 6. Research use only.
The ceiling: 10 (as determined by your healthcare provider based on individual response and tolerance)
Reconstitution, in plain words
Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Ventfort:
Ventfort comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Use Ventfort exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Ventfort's recorded schedule.
Injection sites & technique
Ventfort is placed under the tongue (sublingual) as enteric-coated capsules (capsules coated to dissolve later in the gut)—no injection required
Timing
Take Ventfort at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
Ventfort can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
Ventfort should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
The honest list
These show up most often. They usually fade as your body adjusts.
Mild redness, slight soreness, or minor swelling at the subcutaneous (under the skin) injection site.
What to do Rotate injection sites. Apply cold compress if needed. Resolves within 24-48 hours.
Slight tiredness in the first days as blood vessel remodeling and changes in gene activity get going.
What to do Rest as needed. Usually resolves within 2-3 days.
A short-lived headache in the first few days, possibly linked to changes in blood vessel tightness as the vessel lining starts to work more normally.
What to do Ensure adequate hydration. Standard analgesics if needed. Self-limiting.
Transient mild changes in blood pressure as vascular tone normalizes through eNOS restoration and arterial compliance improvement.
What to do Monitor blood pressure. Usually stabilizes within 1-2 weeks. Consult physician if significant changes occur.
Worth knowing about, but most people never see these.
Occasional mild dizziness during the initial treatment period as vascular tone and blood pressure adjust.
What to do Rise slowly from seated/lying positions. Stay hydrated. Reduce dose if persistent.
Rare, but if any of these happen, stop and contact a medical professional.
No serious adverse events have been reported in published clinical studies including the 49-patient trial. No lethal dose established in animal toxicology research.
What to do As with any cardiovascular-active compound, monitor blood pressure and lipid levels. Discontinue and seek medical attention if unexpected symptoms occur.
Week by week
Is it right for you?
Ventfort should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Use with caution—discuss with your healthcare provider.
Use with caution—discuss with your healthcare provider.
Use with caution—discuss with your healthcare provider.
May be used together under medical guidance.
May be used together under medical guidance.
May be used together under medical guidance.
Generally safe to take alongside Ventfort. Space doses apart if taking oral formulations to ensure optimal absorption.
Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Ventfort is particularly well-suited for individuals focused on cardiovascular geroprotection — preserving vascular function during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ventfort is a good fit for people focused on age-related artery stiffness and endothelial dysfunction (a poorly working blood vessel lining). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ventfort is particularly well-suited for individuals focused on lipid profile optimization as adjunctive support alongside lifestyle modifications. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ventfort is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting cardiovascular health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ventfort (collagen peptide complex) demonstrates excellent safety profile from cosmetic and nutritional supplement use spanning decades. Hydrolyzed collagen peptides pass through the GI tract largely unchanged—minimal systemic (affecting the whole body) absorption occurs, making serious adverse effects unlikely. Mild gastrointestinal side effects (bloating, dyspepsia) occur in <5% of users and are generally self-limiting. Allergic reactions are rare given the high molecular weight peptide fragments; histamine content is negligible in properly processed formulations.
Safety data derives from cosmetic ingredient safety dossiers, nutritional supplement post-market surveillance, and extensive use in sports nutrition (>50,000 athletes globally). Clinical studies in joint health and skin aging support good tolerability across age groups. Non-systemic (affecting the whole body) mechanism (topical or oral non-absorbed) confers inherently lower risk profile compared to systemic peptide therapeutics, with primary safety concerns being contamination during manufacturing rather than peptide pharmacology itself.
Keeping it good
Store Ventfort in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Once reconstituted, Ventfort should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Not our opinion — the published record
2016
Ventfort peptide supports joint cartilage repair and mobility.
Kozlov KL, Bolotov II, Linkova NS, et al.
2014
Research (2014) on ventfort contributes important scientific knowledge about its biological and pharmacological properties.
Kitachev KV, Sazonov AB, Kozlov KL, et al.
2023
Vilon peptide (KE) regulates longevity genes by activating SIRT1 (a gene that helps cells stay healthy as they age) and suppressing PARP1/PARP2 (DNA-repair proteins linked to aging), with anti-aging effects that work through binding to DNA.
Khavinson VK, Linkova NS, Ashapkin VV
2021
Research (2021) on ventfort contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VK, Popovich IG, Linkova NS, et al.
2022
Research confirms testagen's role in supporting male reproductive health.
Khavinson VK, Linkova NS, Pronyaeva VE
2024
Firma Vita / St. Petersburg Institute of Bioregulation and Gerontology
If this isn't the right fit
Your questions
Ventfort is a tissue-derived peptide complex extracted from bovine aorta, containing a mixture of ultrashort peptides up to 5 kDa including the KED (Lys-Glu-Asp) tripeptide. Unlike purely synthetic single-peptide bioregulators (like Vilon/KE or Epithalon/AEDG), Ventfort provides a complex of multiple vascular-specific peptides that work together. This mirrors the approach of Thymalin (thymic extract) and Cortexin (brain extract) — tissue extracts that contain the full spectrum of organ-specific peptides rather than a single purified sequence.
In a controlled clinical study of 49 patients with heart and blood vessel conditions, Ventfort treatment lowered total cholesterol by about 30% over the treatment period. This is attributed to the peptides adjusting which genes are active in the liver and blood vessels that control fat processing. The peptides bind DNA at the control regions of genes that govern cholesterol production, LDL receptors (the liver's cholesterol-clearing docking points), and fat transport, effectively reprogramming fat metabolism at the gene level.
Ventfort should not be considered a replacement for prescribed statin medications, particularly in patients with established cardiovascular disease or high cardiovascular risk. While the 30% cholesterol reduction observed clinically is comparable to moderate-intensity statin therapy, Ventfort lacks the extensive clinical trial evidence base that supports statins. It may be considered as adjunctive support alongside conventional therapy or for individuals who cannot tolerate statins, but always under medical supervision.
Arterial stiffness comes from age-related changes in the scaffolding around vessel cells (the extracellular matrix): loss of elastin (stretchy fibers), more collagen cross-linking (stiffening), and unbalanced MMP activity (enzymes that break down this scaffolding). Ventfort's peptides bind the control regions of genes for elastin, collagen, and MMPs, rebalancing the scaffolding toward a more youthful, elastic state. This is very different from vasodilators, which only temporarily relax vessel walls. Ventfort aims to reverse the structural changes in artery walls.
KED (Lys-Glu-Asp) is a tripeptide (three linked amino acids) identified as a key active part of Ventfort's peptide mixture. It fits into the minor groove of DNA (a narrow channel along the DNA helix) at control sequences of vessel genes, much like Vilon's KE dipeptide binds GCGG sequences in immune genes. KED has been studied on its own and shown to change vessel gene activity, but inside Ventfort it works together with other peptides derived from the aorta (the body's main artery) for broader vessel support.
In Khavinson's bioregulator system, Ventfort addresses cardiovascular aging specifically. A comprehensive anti-aging protocol might include: Ventfort (vascular), Epithalon (pineal/melatonin), Vilon (immune), Cerluten (brain), and organ-specific peptides like Testagen (testicular) or Chonluten (lung) depending on individual needs. These are used in cyclical courses of 10-20 days, repeated every 3-6 months, with each peptide targeting its specific organ system through tissue-specific DNA binding.
6 sources
Every numbered marker on this page points to one of these. Same sources, same numbering as the Ventfort research profile on Peptide Initiative.
Want the deep science?
Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.
Open the research profileThis guide is education, not medical advice. Ventfort is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.